Live tape
Top 8, mentions 7d8,143NKE2,072 mentions▲ +0.03GOOGL1,623 mentions▲ +0.03NVDA1,014 mentions▲ +0.10META967 mentions▲ +0.05TSLA706 mentions▲ +0.06QQQ657 mentions▲ +0.08SPCX553 mentions▲ +0.07SPY551 mentions▲ +0.04

Equity · Healthcare

ANGO

NASDAQ

AngioDynamics, Inc.

$15.12 +0.03% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 2, 2026
Price · Chart
Our own end-of-day closes 64 sessions
$18 $12 6 Jul 2 Oct

The line runs $13 on 6 July through $15.12 on 2 October, on a scale from $12 to $18. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of ANGO over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 64 sessions over that window: $13 on 6 July 2026 through $15.12 on 2 October 2026.

Market cap $635.9M
52-week range $9.70 – $16.08
Avg volume 21.3K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Oct 2, 2026

ANGO insider trades

SEC Form 4 · last 90 days · newest reported trade 30 Jul 2026
Open-market buys 0
Open-market sells 1
Net sold $344K
Non-trade filings 39
Date Insider Type Shares Value
30 Jul 2026 Nighan Warren JR SVP Quality and Regulatory Sell 23,370 $344K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
22 Jul 2026 Campbell Chad Thomas SVP/GM, Vascular Access Option exercise 6,466
22 Jul 2026 Campbell Chad Thomas SVP/GM, Vascular Access Tax withheld 2,330 $32K
22 Jul 2026 Clemmer James C President and CEO Option exercise 52,358
22 Jul 2026 Clemmer James C President and CEO Tax withheld 26,728 $369K
22 Jul 2026 Trowbridge Stephen A EVP and CFO Option exercise 16,296
22 Jul 2026 Trowbridge Stephen A EVP and CFO Tax withheld 8,319 $115K
22 Jul 2026 Nighan Warren JR SVP Quality and Regulatory Option exercise 5,694
22 Jul 2026 Nighan Warren JR SVP Quality and Regulatory Tax withheld 1,671 $23K
22 Jul 2026 Piccinini Laura SVP International Option exercise 8,047
22 Jul 2026 Piccinini Laura SVP International Tax withheld 4,506 $62K
20 Jul 2026 Campbell Chad Thomas SVP/GM, Vascular Access Tax withheld 359 $5K
20 Jul 2026 Clemmer James C President and CEO Tax withheld 4,223 $58K

Showing the 12 most recent of 39 compensation filings in this window. The figures above count all of them.

ANGO reported financials

SEC EDGAR XBRL

ANGO reported revenue of $320.2M for the fiscal year ended 31 May 2026. Net income over the same period was −$36.7M.

Figure Reported Period
Revenue $320.2M 31 May 2026 fiscal year
Net income −$36.7M 31 May 2026 fiscal year
Diluted EPS −$0.88 31 May 2026 fiscal year
Total assets $267.2M 31 May 2026 at period end
Total equity $170.8M 31 May 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 May 2026

ANGO earnings

SEC EDGAR
Date Period EPS Revenue
31 May 2026 FY 2026 $-0.88 —
28 Feb 2026 Q3 2026 $-0.19 —
30 Nov 2025 Q2 2026 $-0.15 —
31 Aug 2025 Q1 2026 $-0.26 —
31 May 2025 FY 2025 $-0.83 —
28 Feb 2025 Q3 2025 $-0.11 —
30 Nov 2024 Q2 2025 $-0.26 —
31 Aug 2024 Q1 2025 $-0.31 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

ANGO institutional holders

SEC Form 13F

9 of the 45 institutional funds we track reported a ANGO position for the quarter ended 30 Jun 2026 — a combined $77.3M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Point72 Asset Management Held (±25%) −3.7% shares 3,062,517 $39.8M
Millennium Management Held (±25%) +21.5% shares 783,125 $10.2M
Renaissance Technologies Held (±25%) −8.6% shares 733,883 $9.5M
AQR Capital Management Added +134.2% shares 589,157 $7.7M
Marshall Wace Held (±25%) −13.4% shares 420,378 $5.5M
Two Sigma Investments Added +32.9% shares 306,260 $4.0M
Tudor Investment Corp Trimmed −58.0% shares 19,453 $253K
Citadel Advisors Trimmed −74.2% shares 12,484 $162K
Balyasny Asset Management New position 12,125 $158K

Source: SEC EDGAR 13F filings

ANGO fails-to-deliver

SEC CNS data

On 04 Sep 2026, 136 shares of ANGO failed to deliver (about $2K).

Settlement date Shares failed Notional % of shares out
04 Sep 2026 136 $2K <0.001%
25 Aug 2026 992 $16K 0.002%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in ANGO

STOCK Act disclosures

The most recent congressional trade disclosed in ANGO is a sale by Debbie Wasserman Schultz (house, FL), dated 16 Jul 2025.

Date Member Type Amount
16 Jul 2025 filed 25 Jul 2025 Debbie Wasserman Schultz house · Democrat–FL Sale $1K–$15K
27 Jun 2025 filed 25 Jul 2025 Debbie Wasserman Schultz house · Democrat–FL Purchase $1K–$15K

Source: U.S. House of Representatives financial disclosures